Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Eggerman

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Diabetes|April 24, 2025
Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic DiseasesCorinne M Silva, Pamela L Thornton, Shavon Artis Dickerson, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Different functions of human scavenger receptors BI and BII overexpressed in a murine abdominal sepsis modelNaoki Hayase, Tatyana G Vishnyakova, Irina N Baranova, et al.
The Journal of Biological Chemistry|January 16, 2010
CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsIrina N Baranova, Alexander V Bocharov, Tatyana G Vishnyakova, et al.
Frontiers in Immunology|April 7, 2023
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantationCassandra Ballou, Franca Barton, Elizabeth H Payne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung InjuryAlexander V Bocharov, Tinghuai Wu, Irina N Baranova, et al.
Diabetes Care|October 17, 2022
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 StudyMichael R Rickels, Thomas L Eggerman, Levent Bayman, et al.
The Journal of Biological Chemistry|December 4, 2004
Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinasesIrina N Baranova, Tatyana G Vishnyakova, Alexander V Bocharov, et al.
Diabetes Technology & Therapeutics|January 29, 2015
Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetesPeter A Senior, Melena D Bellin, Rodolfo Alejandro, et al.
Plos One|October 15, 2020
SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formationTatyana G Vishnyakova, Alexander V Bocharov, Irina N Baranova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2006
CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cellsTatyana G Vishnyakova, Roger Kurlander, Alexander V Bocharov, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Diabetes|April 24, 2025
Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic DiseasesCorinne M Silva, Pamela L Thornton, Shavon Artis Dickerson, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Different functions of human scavenger receptors BI and BII overexpressed in a murine abdominal sepsis modelNaoki Hayase, Tatyana G Vishnyakova, Irina N Baranova, et al.
The Journal of Biological Chemistry|January 16, 2010
CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsIrina N Baranova, Alexander V Bocharov, Tatyana G Vishnyakova, et al.
Frontiers in Immunology|April 7, 2023
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantationCassandra Ballou, Franca Barton, Elizabeth H Payne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung InjuryAlexander V Bocharov, Tinghuai Wu, Irina N Baranova, et al.
Diabetes Care|October 17, 2022
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 StudyMichael R Rickels, Thomas L Eggerman, Levent Bayman, et al.
The Journal of Biological Chemistry|December 4, 2004
Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinasesIrina N Baranova, Tatyana G Vishnyakova, Alexander V Bocharov, et al.
Diabetes Technology & Therapeutics|January 29, 2015
Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetesPeter A Senior, Melena D Bellin, Rodolfo Alejandro, et al.
Plos One|October 15, 2020
SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formationTatyana G Vishnyakova, Alexander V Bocharov, Irina N Baranova, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2006
CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cellsTatyana G Vishnyakova, Roger Kurlander, Alexander V Bocharov, et al.
Pageof 5